AlaskaDenise
In Memoriam
While the researchers are monitoring the genetic sequences for changes, the first awareness of those changes may come from "boots on the ground", i.e., knowledgeable HCW, "flubies", or media reports - days or weeks before any sequence test can define & confirm any changes.
What symptoms/outcomes will the various highly-probably changes produce?
Compiling a list may prove useful.
---------------------------------------------------
PB2/627K (replication temperature switch):
- more agressive infections - fewer "mild cases"
NA/274Y or 294S - (anti-viral oseltamivir-tamilfu- resistance)
- no response to anti-viral therapy, with more serious infections & deaths
(for now, I won't list the high-path NS1 or poly-basic cleavage site, as hopefully they're less probable in the near future)
Are there any other specific symptom or outcome changes?
---------------------------------------------------------
Specific changes to watch for:
1 - non-response to anti-viral therapy.
2 - increase in % of cases with serious illness
3 - increase in expected death rates
others?
.
What symptoms/outcomes will the various highly-probably changes produce?
Compiling a list may prove useful.
---------------------------------------------------
PB2/627K (replication temperature switch):
- more agressive infections - fewer "mild cases"
NA/274Y or 294S - (anti-viral oseltamivir-tamilfu- resistance)
- no response to anti-viral therapy, with more serious infections & deaths
(for now, I won't list the high-path NS1 or poly-basic cleavage site, as hopefully they're less probable in the near future)
Are there any other specific symptom or outcome changes?
---------------------------------------------------------
Specific changes to watch for:
1 - non-response to anti-viral therapy.
2 - increase in % of cases with serious illness
3 - increase in expected death rates
others?
.